Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma

Status unconfirmed · Phase 1

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. Immunotoxin therapy may be an effective treatment for glioblastoma multiforme and anaplastic astrocytoma. PURPOSE: Phase I trial to study the effectiveness of immunotoxin therapy in treating children who have progressive or recurrent glioblastoma multiforme or anaplastic astrocytoma

Key facts

Study ID

NCT00052624

Run by

Xenova Biomedix

Starts

2002-07-01

Last updated by the study team

2018-05-15

Who can join

Age: 5 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Children's Hospital of Orange County — Orange, California, United States
• Hollings Cancer Center at Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.